In the small intestine, local immune mechanisms may depend largely on the production and secretion of immunoglobulin A (IgA) antibody. In this regard emphasis has been placed on the role of the small intestinal Peyer's patches as a preferential site of antigen absorption (1, 11) , as the site of generation of the precursors of IgAproducing cells (3), and as a significant contributor to the development of intestinal secretary IgA responses (15) .
In attempting to define the protective mechanisms initiated by oral vaccines in the mouse typhoid model, we have found that certain bacterial strains provoke a more vigorous IgA response than others. In this paper we describe the antibody responses that develop after oral immunization with several Salmonella and Escherichia coli strains as well as with hybrid strains. There appeared to be a correlation between the oral immunogenicity of these strains and their ability to survive and grow in the small intestinal Peyer's patches.
MATERIALS AND METHODS
Bacteria. The relevant characteristics of the strains used are summarized in Table 1 .
All strains were stored in agar stabs at 40C. Bacteria were routinely grown to log phase in double-strength Difco nutrient broth, harvested by centrifugation, and resuspended in phosphate-buffered saline (PBS). Glutaraldehyde-fixed bacteria were prepared by treating bacteria at a density of 10'0/ml with 1% glutaraldehyde in PBS for 30 min at 20'C. The bacteria were washed free of glutaraldehyde by four cycles of centrifugation.
Mice. BALB/c mice and specific pathogen-free mice of the LAC strain were used when 6 to 8 weeks of age. Mice were allowed free access to a commercial mouse food and water.
Immunization. For oral immunization, mice were given 0.5 ml of bacterial suspension in PBS, further buffered by the addition of 3% NaHCO3. Doses were delivered intragastrically by a syringe fitted with a blunt-ended 19 gauge needle. Serum and intestinal fluid. Mice were bled from the retro-orbital plexus, and the sera were pooled and stored at -20'C. Intestinal fluid was collected by passing 5 ml of PBS containing 0.05% bovine serum albumin (PBS-BSA) through the small intestine of each mouse and collecting this washout. This material was pooled for each group of mice and centrifuged at 10,000 x g for 20 min at 40C, and the supernatant was harvested and stored at -20'C. This 5-ml washout was considered as a 1/25 dilution for the radioimmunoassay (RIA); in other words, the assumption was made that the original mouse small intestine contained 0.2 ml of material.
RIA. This procedure has been described (5) Antibody-forming cell assays. A thin-layer modification of the Jerne plaque-forming cell (PFC) assay was used to determine the number of spleen cells secreting specific anti-08-lipopolysaccharide antibody. BALB/c mice were fed two doses of 2 x i09 bacteria on alternate days. Twenty-one days after the last dose, the spleens were removed and homogenized with a loose-fitting ground glass tissue homogenizer, and the number of viable mononuclear cells was determined by trypan blue exclusion. A 100-Mul volume of spleen cell suspension and 100 tLI of a 10% suspension of either normal sheep erythrocytes or E. coli lipopolysaccharide-08-coated sheep erythrocytes were added to a tube containing 2 ml of 0.75% agarose in Hanks balanced salt solution and 0.25% BSA held at 480C. The tube was immediately mixed, and the contents were spread into a 100-mm-diameter plastic petri dish, allowed to solidify, and incubated at 370C for 45 min in a moist atmosphere. At this time 2 ml of 1/20 guinea pig serum, previously absorbed with 08-lipopolysaccharide-coated sheep erythrocytes, was added to the surface of the agarose layer, and incubation was continued for 45 min at 370C. The guinea pig serum was then removed, and the number of plaques was marked on the bottom of the petri dish. A dilution of goat anti-mouse IgA was added and incubated for 45 min at 370C, and then a further 2 ml of 1/20 guinea pig was serum added and the plates were incubated for a final 45 min, at which time the additional plaques that developed were enumerated. These additional plaques, developed by addition of goat anti-mouse IgA, were termed IgA PFCs.
Recovery and enumeration of bacteria from mice. At specified times after oral dosing, groups of four to five mice were killed by cervical dislocation, and the small intestines were removed and freed from the mesentery. Ten milliliters of saline was washed through the small intestine and discarded. The Peyer's patch tissue was removed by snipping off the Peyer's patch, plus a small amount of surrounding tissue, from the serosal surface. The Peyer's patches and the remainder of the small intestine were homogenized separately in ice-cold saline with an Ultra-Turrax homogenizer (Janke and Kunkel, West Germany). These homogenates were appropriately diluted and spread on the surface of Endo-agar plates, which were then incubated for 18 h at 370C. The identity of the bacterial colonies was confirmed by agglutination in specific antiserum.
RESULTS
Antibody levels after oral immunization. 3 <20 <20 <20 <20 <20 <20 5 <20 <20 <20 <20 <20 <20 7 <20 <20 <20 <20 <20 <20 12 <20 <20 <20 <20 <20 <20 80 320 (40) <20 <20 160 a As measured by radioimmunoassay against strain F1142 (04, 5, 12) . Antibody levels are expressed as the reciprocal of the highest dilution binding greater than 10% of the total counts added.
b Specific pathogen-free LAC strain mice were fed six triweekly doses of 10'0 bacteria. ' Day after dose 6. oral doses of S. typhimurium hybrid F885 showed higher levels in both serum and intestinal fluid.
In another experiment, mice were fed two oral doses, each containing 3 x 109 viable bacteria, of either Salmonella stanley, Salmonella derby, or E. coli hybrid F1142 and were boosted i.p. 14 days after the last oral dose with 2 x 106 live E. coli F1142. Sera and intestinal fluids were obtained on day 7 after the i.p. boost. The levels of specific antibody in the sera and intestinal fluids as determined by RIA using F1142 (04, 5, and 12) indicated that S. stanley more efficiently primed mice for response to these antigens than did S. derby and E. coli hybrid F1142 (see Fig.  2 ). Despite differences in antigenicity of these three strains (see Table 1 ), the majority of the antibody response in all cases was directed against the 04 antigen.
Number of anti-08 PFC in the spleens of orally immunized BALB/c mice. After two oral doses of either S. typhimurium hybrid F885 (08) or E. coli F492 (08), the numbers ofplaques formed as a result of anti-08 antibody-forming cells in the spleen were measured (Table 4) . It can be seen that BALB/c mice developed measurable PFCs by day 21 when fed strain F885, and showed an increased level on day 28, but very few PFCs were detected on day 35. In these mice, PFCs due to IgA were predominant. The serum antibodies detected by RIA were correspondingly largely of the IgA type. Oral dosing with E. coli F492 produced no detectable PFCs by day 21, but reasonable numbers by day 35, although it should be noted that only a minority of these formed IgA. This is consistent with the finding that no anti-08 IgA antibodies were detected in the serum by RIA. Intestinal IgA antibodies were detected only in mice fed with the S. typhimurium hybrid F885. Distribution of live bacterial vaccines in the small intestinal Peyer's patches after oral dosing. All of the strains examined appeared in small numbers in the Peyer's patches of the small intestine 1 day after mice were fed 1010 bacteria (Fig. 3A) . E. coli F492 multiplied approximately fivefold by day 2 but could no longer be detected at day 3. Strain F1142 was eliminated by day 2. In contrast, both F885 and G30 increased in numbers for several days, at which point they began to decrease steadily. By day 21 F885 was no longer detectable, and G30 was present only in very small numbers.
S. stanley and S. derby showed differences in ability to colonize the Peyer's patches. S. stanley behaved in a manner similar to that seen with F885 and G30, whereas S. derby appeared in smaller numbers at day 1 and virtually disappeared by day 6 (Figure 3B ). The number of bacteria present in the remainder of the small intestinal wall (non-Peyer's patch tissue) closely paralleled the numbers found in the Peyer's patches except with strain G30, which was not detected in the small intestinal wall after day 2. With strains F885 and S. Stanley greater numbers of bacteria were always recovered from the Peyer's patches than from the remainder of the small intestine after 2 days, although this tissue represents only a small fraction of the total small intestine. Despite multiplication within the Peyer's patches, strains G30, F885, and S. stanley were not normally found in the spleens of immunized mice. DISCUSSION Despite the ability of a hybrid strain of E. coli expressing Salmonella 0 antigens 4, 5, 12 and (8) to stimulate a significant level of antibody and specific immunity after parenteral immunization when parenterally challenged with S. typhimurium (7), a similar hybrid strain (F1142) was found to be only weakly immunogenic when given orally (Table 3 ). The antibody responses to the 0 antigens 4, 5, and 12 after six oral doses of this live hybrid were not much better than those obtained with the same doses of killed S. typhimurium C5. In contrast, the same oral regimen of live avirulent galactose-epimerase-negative strain S. typhimurium G30 resulted in significant elevation of both serum and intestinal antibody levels to one or more of the 4, 5, or 12 antigens.
It seems most likely that the markedly different immunogenicity of strain G30 and strain F1142 is determined by their respective abilities to colonize the small intestinal Peyer's patch (Fig. 3A) . There seems little doubt that the persistence of strain G30 allowed presentation of more antigen in the Peyer's patches over a longer period than occurred with either killed strain C5 or live strain F1142. In addition, antigen replication by strain G30 within the Peyer's patches probably results in more antigen reaching parenteral lymphoid tissue and thus more efficiently immunizing the whole animal.
It can be noted (Table 3 ) that no response was detected until 21 days after the last oral dose (33 days after the first dose) and that both serum and intestinal antibody appeared at this time. Intestinal IgA antibody has been shown not to reach maximal levels until 21 days after oral infection of mice with S. typhimurium and this antibody persisted at this level for 11 to 13 weeks (17). Although one report has shown a large rise in serum antibody levels, which first appears 4 weeks after commencement of chronic feeding of BSA to rabbits (2), it has been more commonly demonstrated that the secretary IgA response occurs rapidly and is of short duration (4, 6, 12, 15, 16) after local stimulation by different antigens. The duration of local responses may be influenced by the persistence of antigen, but the reason for the delayed response after Salmonella feeding (Table 3; 17) is not apparent.
It has been previously demonstrated under a variety of experimental conditions that local intestinal immunization when followed by parenteral boosting can significantly elevate the local antibody response over that developed by either oral or parenteral doses alone (13, 14, 16) . We have found that after this type of vaccine schedule the specific pathogen-free LAC mouse strain will respond according to the type of local immunization given. Again, it was found that the ability of a strain to colonize the Peyer's patches profoundly influenced the immunogenicity of the oral bacterial vaccine. Strains F885 and F492 both express the E. coli 0 antigen 8 as their sole O antigen. Despite other differences in these two strains, such as motility and genetic and phenotypic background, their most marked difference in vivo is the ability of strain F885 to multiply and persist within the small intestinal Peyer's patches while strain F492 is quickly eliminated (Fig. 3A) . In terms of priming mice for an IgA response to the 08 antigen, these two strains are markedly different with the strain F885 priming for much increased serum and intestinal IgA antibody responses (Fig. 1) . (Fig. 3B ). S. stanley, which multiplied and persisted in the small intestinal Peyer's patches whereas two other strains carrying group B antigens did not, primed much more effectively for IgA production (Fig. 2) .
S
The lack of immunogenicity of the nonpersistent E. coli hybrid strains when given orally Y casts some doubt on the potential effectiveness of hybrid E. coli oral vaccines. Although the mechanisms of immunity to schigellosis is not as yet determined, the failure of an E. coli hybrid strain expressing Shigella somatic antigens to be effective as an oral vaccine (9) may be related to the same phenomenon of persistence. If local IgA production is to be of any particular prophylactic value against mucosal infections, those vaccines that colonize the Peyer's patches, a characteristic that appears to be associated with the most efficient production of IgA, could be the most protective form of oral immunization.
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